ARK Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

ARK Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.03M	Buy	120,874 +30,621	+34%	+$513K	0.01%	138
2025 Q1	$1.39M	Sell	90,253 -10,190	-10%	-$157K	0.01%	156
2024 Q4	$2.21M	Sell	100,443 -23,422	-19%	-$516K	0.02%	128
2024 Q3	$2.23M	Sell	123,865 -45,555	-27%	-$821K	0.02%	132
2024 Q2	$2.75M	Sell	169,420 -22,716	-12%	-$369K	0.02%	131
2024 Q1	$2.71M	Sell	192,136 -30,670	-14%	-$433K	0.02%	149
2023 Q4	$2.33M	Sell	222,806 -32,004	-13%	-$334K	0.01%	159
2023 Q3	$2.6M	Buy	254,810 +16,887	+7%	+$172K	0.02%	143
2023 Q2	$1.79M	Buy	237,923 +26,145	+12%	+$197K	0.01%	185
2023 Q1	$1.87M	Sell	211,778 -47,385	-18%	-$419K	0.01%	176
2022 Q4	$2.36M	Sell	259,163 -76,305	-23%	-$696K	0.02%	158
2022 Q3	$2.71M	Buy	335,468 +102,950	+44%	+$831K	0.02%	150
2022 Q2	$2.12M	Sell	232,518 -67,494	-22%	-$614K	0.01%	184
2022 Q1	$2.82M	Sell	300,012 -4,780	-2%	-$44.9K	0.01%	184
2021 Q4	$2.44M	Sell	304,792 -99,204	-25%	-$794K	0.01%	232
2021 Q3	$3.94M	Sell	403,996 -108,446	-21%	-$1.06M	0.01%	200
2021 Q2	$5.07M	Buy	512,442 +12,598	+3%	+$125K	0.01%	234
2021 Q1	$5.77M	Buy	499,844 +320,042	+178%	+$3.69M	0.01%	204
2020 Q4	$1.74M	Buy	179,802 +104,715	+139%	+$1.01M	﹤0.01%	187
2020 Q3	$677K	Sell	75,087 -24,905	-25%	-$225K	﹤0.01%	179
2020 Q2	$1.23M	Buy	99,992 +43,869	+78%	+$541K	0.01%	140
2020 Q1	$504K	Buy	56,123 +9,994	+22%	+$89.7K	0.01%	128
2019 Q4	$452K	Sell	46,129 -10,569	-19%	-$104K	0.01%	136
2019 Q3	$390K	Buy	56,698 +22,291	+65%	+$153K	0.01%	168
2019 Q2	$318K	Buy	34,407 +9,945	+41%	+$91.9K	0.01%	175
2019 Q1	$384K	Buy	24,462 +856	+4%	+$13.4K	0.01%	156
2018 Q4	$364K	Buy	23,606 +543	+2%	+$8.37K	0.01%	136
2018 Q3	$497K	Sell	23,063 -7,424	-24%	-$160K	0.02%	146
2018 Q2	$741K	Buy	30,487 +2,561	+9%	+$62.2K	0.03%	105
2018 Q1	$477K	Buy	27,926 +10,762	+63%	+$184K	0.02%	142
2017 Q4	$325K	Buy	+17,164	New	+$325K	0.03%	119